Background: Prolonged use of electronic devices poses a significant risk of Computer vision syndrome (CVS). Computer Vision syndrome is emerging as the next unexpected epidemic of the COVID era. Almost all children attending regular online schools are suffering from mild to severe Computer vision syndrome. Besides health problems, CVS also results in concentrate difficulties in studies and decrease a child’s performance. Awareness regarding CVS is increasing among folks of all ages since it has hit not just school going children but their parents as well who are pursuing work from home. Materials and Methods: From March 2020 to March 2021, a multidisciplinary study was conducted to look at the increase in CVS and related factors among school-age children in School of Scholars, Nagpur taking online classes. The randomized controlled trial was used to select 600-school aged children between the ages of 8 and 17, and data was collected using a systematic questionnaire completed by the children's parents. Results: CVS was found in 345 (57.5%) of the 600 children studied, which is very concerning. With proportions of 83.50 percent, 66.33 percent, and 62.17 percent, respectively, the most common reported signs of CVS were eyestrain, eye inflammation, and eye pain. CVS are linked to daily screen use and pre-existing eye disorder. Conclusion: To deter CVS, it is critical to reduce screen time, improve parent and child understanding of safety precautions, and receive management support. To protect a child's overall well-being, we encourage policymakers and parents to restrict e-learning, since it will never be a suitable replacement for conventional classroom instruction.

Obesity has assumed a pandemic and is responsible for serious medical, social, psychological, and economic implications, affecting all ages and socioeconomic groups. Hence, this prospective study was carried out to study the surgical benefits in such patients. A Prospective interventional study was carried out from June 2010 to November 2012 at IGGMC Nagpur performing laparoscopic sleeve gastrectomy (LSG) in morbidly obese patients, and its efficacy was determined. A total of 56 patients were studied. 26 (46.42 %) being males and 30 (53.57 %) females. The maximum number of patient's, i.e., 32 (57.14 %) were in the range of BMI 40-44.99 kg/m(2) with mean BMI-43.25 kg/m(2). Mean weight was 117 kg (range 92-180 kg). Common comorbidities observed were hypertension in 43 (76.78 %), bronchial asthma in 31 (55.35 %), and diabetes in 21 (37.5 %). All patients treated with LSG had a mean operative time of 154.9 min (range 110-310 min) with 0 % leak, one conversion to open, and no mortality. Postoperative hospital stay was 3.54 days (range 3-7). Complications were minimal with prolonged vomiting seen significantly in 28 (50 %) patients. Follow up at 24 months showed mean weight 74.72 kg (68-81 kg) with mean excess weight loss of 67.71 % (62.79-71.05 %) causing a mean BMI of 28.42 kg/m(2) (26.56-30.44 kg/m(2)). It also reduced mean BP to 120.36 mmHg (110-144 mmHg) and mean fasting blood sugar to 100.63 mg/dl (80-146 mg/dl). Surgery for obesity is definitely an answer for this gift of modernization, and LSG is a safe and effective technique for achieving weight loss. Quality of life improves astonishingly and adds confidence to this mentally traumatic entity called "OBESITY".